Figure 3.
Effect of CD33 expression levels on (A) overall survival and (B) relapse in GO versus no GO randomised AML patients
Forest plot analysis of 393 non-CBF patients assessable for GO vs no GO comparison. Patients were stratified into CD33 expression quartile using CD33-MFI and %CD33-positivity.